Performance of Cervical Cancer Screening Techniques in HIV-Infected Women in Uganda

Journal of Lower Genital Tract Disease

Volumn 19, Issue 3, 2015, Pages 215-219

  Bansil, Pooja ^a   Lim, Jeanette ^a   Byamugisha, Josaphat ^b   Kumakech, Edward ^c   Nakisige, Carol ^d   Jeronimo, Jose A ^a  

^a PATH   (United States)

^b MAKERERE UNIVERSITY   (Uganda)

^c PATH   (Uganda)

^d MULAGO NATIONAL REFERRAL HOSPITAL   (Uganda)

Author keywords

cervical cancer; HIV; human papillomavirus (HPV); screening tests; Uganda

Indexed keywords

ACETIC ACID;

ADOLESCENT; ADULT; ARTICLE; CANCER SCREENING; CERVICAL CARE HUMAN PAPILLOMA VIRUS; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; SCREENING TEST; SENSITIVITY AND SPECIFICITY; UGANDA; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VAGINAL CARE HUMAN PAPILLOMA VIRUS; VIRUS LOAD; VISUAL SYSTEM EXAMINATION; CERVICAL INTRAEPITHELIAL NEOPLASIA; COMPLICATION; EARLY CANCER DIAGNOSIS; HIV INFECTIONS; ISOLATION AND PURIFICATION; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROCEDURES; UTERINE CERVICAL NEOPLASMS; VAGINA SMEAR; VIROLOGY; WOMEN'S HEALTH;

ACETIC ACID; ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; EARLY DETECTION OF CANCER; FEMALE; HIV INFECTIONS; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SENSITIVITY AND SPECIFICITY; UGANDA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; WOMEN'S HEALTH;

EID: 84937728099     PISSN: 10892591     EISSN: 15260976     Source Type: Journal    
DOI: 10.1097/LGT.0000000000000090     Document Type: Article

References (19)

1. Parkin DM, Ferlay J, Curado MP, Bray F, Edwards B, Shin HR, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-917.
2. Cuzick J, Clavel C, Petry KU, Meijer CJ, Hoyer H, Ratnam S, et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 2006;119:1095-101.
3. Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med 2007;357:1579-88.
4. Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, Gordillo-Tobar A, Levin C, Mahé C, et al. Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med 2005;353:2158-68.
5. Franceschi S, Jaffe H. Cervical cancer screening of women living with HIV Infection: a must in the era of antiretroviral therapy. Clin Infect Dis 2007;45:510-3.
6. Anderson J, Lu E, Sanghvi H, Kibwana S, Lu A. Cervical cancer screening and prevention for HIV-infected women in the developing world. In: Georgakilas A, ed. Cancer Prevention: From Mechanisms to Translational Benefits. Rijeka, Croatia: InTech; 2012;231-60.
7. Qiao YL, Sellors JW, Eder PS, Bao YP, Lim JM, Zhao FH, et al. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol 2008;9:929-36.
8. Jeronimo J, Bansil P, Lim J, Peck R, Paul P, Amador JJ, et al. A multicountry evaluation of careHPV™ testing, visual inspection with acetic acid, and Pap testing for the detection of cervical pre-cancer and cancer. Int J Gynecol Cancer 2014;24:576-85.
9. Serwadda D, Wawer MJ, Shah KV, Sewankambo NK, Daniel R, Li C, et al. Use of a hybrid capture assay of self-collected vaginal swabs in rural Uganda for detection of human papillomavirus. J Infect Dis 1999;180:1316-9.
10. Parham GP, Sahasrabuddhe VV, Mwanahamuntu MH, Shepherd BE, Hicks ML, Stringer EM, et al. Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. Gynecol Oncol 2006;103:1017-22.
11. Clifford GM, Gonçalves MA, Franceschi S, HPV and HIV Study Group. Human papillomavirus types among women infected with HIV: a meta-analysis. AIDS 2006;20:2337-44.
12. Banura C, Mirembe FM, Katahoire AR, Namujju PB, Mbonye AK, Wabwire FM. Epidemiology of HPV genotypes in Uganda and the role of the current preventive vaccines: a systematic review. Infect Agent Cancer 2011;6:11.
13. US Centers for Disease Control and Prevention. 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults. MMWR 1990; 39(No. RR-13):39-40.
14. US President's Emergency Plan for AIDS Relief (PEPFAR) [Internet]. Partnership to Fight HIV/AIDS in Uganda [cited 2013 Dec 27]. Available from: http://www.pepfar.gov/countries/uganda/index.htm.
15. Uganda Ministry of Health (MOH), ICF International. 2011 Uganda AIDS Indicator Survey: Key Findings. Calverton, MD: MOH and ICF International; 2012.
16. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality, and Prevalence Worldwide [Internet]. Lyon, France: International Agency for Research on Cancer [cited 2013 Dec 27]. Available from: http://globocan.iarc.fr/.
17. King R, Katuntu D, Lifshay J, Packel L, Batamwita R, Nakayiwa S, et al. Processes and outcomes of HIV serostatus disclosure to sexual partners among people living with HIV in Uganda. AIDS Behav 2008;12:232-43.
18. Kuhn L, Wang C, Tsai WY, Wright TC, Denny L. Efficacy of human papillomavirus-based screen-and-treat for cervical cancer prevention among HIV-infected women. AIDS 2010;24:2553-61.
19. Ogilvie GS, Mitchell S, Sekikubo M, Biryabarema C, Byamugisha J, Jeronimo J, et al. Results of a community based cervical cancer screening pilot project using HPV self-sampling in Kampala, Uganda. Int J Gynaecol Obstet 2013;122:118-23.